Skip to content

Suresh Yerra

NPI 1750069142ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· Phoenix, AZ

Internal Medicine, Advanced Heart Failure and Transplant Cardiology in Phoenix, Arizona, licensed in AZ, with an NPI issued in July 2023. Part D covered 101 prescriptions written in 2024, 53% of them generic. Abbott Laboratories was the largest of 2 companies reporting payments in 2024, $290.35 in all, mostly food and beverage.

Overview

NPI1750069142
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedJul 6, 2023
Last updated in NPPESJul 27, 2023
Certified by providerJul 27, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)101 · 163 30-day fills
Patients20
Total drug cost$35,183
Generic share53% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$290.35 · 3 payments from 2 companies

Top paying companies in 2024

What the 2024 payments were for

  • Food and Beverage$290.35 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Phoenix

All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Arizona →